Associate Professor, Neurology, University of Florida College of Medicine
Neurology
Dr. Irene A. Malaty, MD
|
|
Give Review
Irene Malaty practices Neurology. She researched medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine She received awards:"CMS Meaningful Use Stage 1 Certification". Irene A. Malaty, MD is a published physician. She has 54 publications published. The most current publication "The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond." She accepts Medicare payments and is listed with Medicare.gov.
Publications
- The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.
- Defining the clinically meaningful difference in gait speed in persons with Parkinson Disease.
- Updates in medical and surgical therapies for Tourette Syndrome.
- An Independent Elderly Woman With Rapid Onset of Coma.
- Timed Up and Go, Cognitive, and Quality of Life Correlates in Parkinson's Disease.
- Mobility, mood and site of care impact health related quality of life in Parkinson's Disease.
- Deep Brain Stimulation May Improve Quality of Life in People With Parkinson's Disease Without Affecting Caregiver Burden.
- Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson's Disease.
- High rates and the risk factors for emergency room visits and hospitalization in Parkinson's Disease.
- A trial of scheduled deep Brain stimulation for Tourette syndrome: moving away from continuous deep Brain stimulation paradigms.
- Quantitative normative gait data in a large cohort of ambulatory persons with Parkinson's Disease.
- What are the issues facing Parkinson's Disease patients at ten years of Disease and beyond?: Data from the NPF-QII study.
- Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's Disease.
- Taking a Better History for Behavioral Issues Pre- and Post-Deep Brain Stimulation: Issues Missed by Standardized Scales.
- Improvement of Both Dystonia and Tics With 60Hz Pallidal Deep Brain Stimulation.
- DBS Candidates That Fall Short on a Levodopa Challenge Test: Alternative and Important Indications.
- Unilateral GPi-DBS as a Treatment for Levodopa-Induced Respiratory Dyskinesia in Parkinson Disease.
- Alternate but do not swim: a test for executive motor dysfunction in Parkinson Disease.
- Did General Douglas MacArthur have Parkinson Disease?: A video and archival analysis.
- Rescue leads: A salvage technique for selected patients with a suboptimal response to standard DBS therapy.
- Hospitalization in Parkinson Disease: A survey of National Parkinson Foundation Centers.
- Steady or not following thalamic deep Brain stimulation for essential tremor.
- Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot Study.
- The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.
- Binge eating in Parkinson's Disease: prevalence, correlates and the contribution of deep brain stimulation.
- A closer look at unilateral versus bilateral deep Brain stimulation: results of the National Institutes of Health COMPARE cohort.
- Brain penetration effects of microelectrodes and deep Brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor.
- Clonazepam and botulinum toxin for the treatment of alien limb phenomenon.
- Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis.
- Hypertensive urgency: an important aetiology of rebound hypertension.
- The "brittle response" to Parkinson's Disease medications: characterization and response to deep brain stimulation.
- An eight-year clinic experience with clozapine use in a Parkinson's Disease clinic setting.
- Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS.
- A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.
- Postural/Gait and cognitive function as predictors of driving performance in Parkinson's Disease.
- The relationship between anosmia, constipation, and orthostasis and Parkinson''s Disease duration: results of a pilot study.
- Mood and motor effects of thalamic deep Brain stimulation surgery for essential tremor.
- The impact of and the factors associated with drooling in Parkinson''s Disease.
- Quetiapine improves visual hallucinations in Parkinson Disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnograph...
- The number and nature of emergency department encounters in patients with deep Brain stimulators.
- Role of rasagiline in treating Parkinson''s Disease: Effect on Disease progression.
- Differential response of dystonia and parkinsonism following globus pallidus internus deep Brain stimulation in X-linked dystonia-parkinsonism (Lubag).
- Piloting the NPF data-driven quality improvement initiative.
- Is rhinorrhea an under-recognized intrinsic symptom of Parkinson Disease? A prospective pilot study.
- Management of the hospitalized patient with Parkinson''s Disease: current state of the field and need for guidelines.
- The distal partial trisomy 1q Syndrome and dystonic tremor.
- Measurement of patient-centered outcomes in Parkinson''s Disease: what do patients really want from their treatment?
- An evaluation of rating scales utilized for deep Brain stimulation for dystonia.
- Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control.
- Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
- Do Stable Patients with a Pre-Morbid Depression History Have a Worse Outcome Following DBS for Parkinson's Disease.
- Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical Dystonia symptoms.
- Usefulness of screening tools for predicting driving performance in people with Parkinson's Disease.
Schools
University Of Florida College Of Medicine
Procedures Preformed
- EEG (Electroencephalogram)
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Florida -
St Vincent Hospital and Health Care Center -
Indiana University School of Medicine
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1134295694 | |
| NPPES Provider LastName | MALATY | |
| NPPES Provider FirstName | IRENE | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 1029.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134295694 |
| Last Name Of The Provider | MALATY |
| First Name Of The Provider | IRENE |
| View All |
Similar Doctors
|
|
Dr. Sankarasubramoney H. Subramony, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Triggs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vidya P. Kulkarni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy P. George, MD |
|
|
Dr. Ivan A. Lopez, MD |
|
|
Dr. Ge Xiong, MD
This Doctor is OpenDoctor Recommended.
|